A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma, Patrick Y. Wen, David A. Reardon, Terri S. Armstrong, Surasak Phupanich, Robert D. Aiken, Joseph C. Landolfi, William T. Curry, Jay-Jiguang Zhu, Michael Glantz, David M. Peereboom, James M. Markert, Renato LaRocca, Donald M. O'Rourke, Karen Fink, Lyndon Kim, Michael Gruber, Glenn J. Lesser, Edward Pan, Santosh Kesari, Alona Muzikansky, Clemencia Pinilla, Radleigh Santos, John S. Yu
Radleigh Santos

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma, Patrick Y. Wen, David A. Reardon, Terri S. Armstrong, Surasak Phupanich, Robert D. Aiken, Joseph C. Landolfi, William T. Curry, Jay-Jiguang Zhu, Michael Glantz, David M. Peereboom, James M. Markert, Renato LaRocca, Donald M. O'Rourke, Karen Fink, Lyndon Kim, Michael Gruber, Glenn J. Lesser, Edward Pan, Santosh Kesari, Alona Muzikansky, Clemencia Pinilla, Radleigh Santos, John S. Yu
Mathematics Faculty Articles

Association of Survival and Progression-Free Survival with Immune Response in HLA-A2+ Newly- Diagnosed GBM Patients in Randomized Double-Blind Placebo-Controlled Phase 2 Trial of Dentritic Cell (DC) Immunotherapy with ICT-107, Patrick Wen, David Reardon, Surasak Phuphanich, Robert Aiken, Joseph Landolfi, William Curry, Jay-Jiguang Zhu, Michael Glantz, David Peereboom, James Markert, Renato Larocca, Donald O'Rourke, Karen Fink, Lyndon Kim, Michael Gruber, Glenn Lesser, Ed Pan, Radleigh Santos, Clemencia Pinilla, John Yu
Mathematics Faculty Proceedings, Presentations, Speeches, Lectures